The DOI matches its Crossref record; 105 of the 108 references it cites were found in a registry or an index.
Glaucoma as a Metabolic Optic Neuropathy: Making the Case for Nicotinamide Treatment in Glaucoma
Open accessAbstract
Mitochondrial dysfunction may be an important, if not essential, component of human glaucoma. Using transcriptomics followed by molecular and neurobiological techniques, we have recently demonstrated that mitochondrial dysfunction within retinal ganglion cells is an early feature in the DBA/2J mouse model of inherited glaucoma. Guided by these findings, we discovered that the retinal level of nicotinamide adenine dinucleotide (NAD, a key molecule for mitochondrial health) declines in an age-dependent manner. We hypothesized that this decline in NAD renders retinal ganglion cells susceptible to damage during periods of elevated intraocular pressure. To replete NAD levels in this glaucoma, we administered nicotinamide (the amide of vitamin B 3). At the lowest dose tested, nicotinamide robustly protected from glaucoma (~70% of eyes had no detectable glaucomatous neurodegeneration). At this dose, nicotinamide had no influence on intraocular pressure and so its effect was neuroprotective. At the highest dose tested, 93% of eyes had no detectable glaucoma. This represents a ~10-fold decrease in the risk of developing glaucoma. At this dose, intraocular pressure still became elevated but there was a reduction in the degree of elevation showing an additional benefit. Thus, nicotinamide is unexpectedly potent at preventing this glaucoma and is an attractive option for glaucoma therapeutics. Our findings demonstrate the promise for both preventing and treating glaucoma by interventions that bolster metabolism during increasing age and during periods of elevated intraocular pressure. Nicotinamide prevents age-related declines in NAD (a decline that occurs in different genetic contexts and species). NAD precursors are reported to protect from a variety of neurodegenerative conditions. Thus, nicotinamide may provide a much needed neuroprotective treatment against human glaucoma. This manuscript summarizes human data implicating mitochondria in glaucoma, and argues for studies to further assess the safety and efficacy of nicotinamide in human glaucoma care.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source says what the claim attributes to it.
In the citing paper
“Recent work has strongly implicated energy deficits in glaucoma [18–23], and reduced AMPK correlates with anti-inflammatory responses and RGC protection [24].”
From AMPK hyperactivation promotes dendrite retraction, synaptic loss, and neuronal dysfunction in glaucoma (2021) · cites this paper as [22]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The number of people with glaucoma worldwide in 2010 and 2020
Quigley, H. A. (2006) · British Journal of Ophthalmology · doi:10.1136/bjo.2005.081224 · Cited by 7,417
A Simple Practice Guide for Dose Conversion between Animals and Human
Nair, A., & Jacob, S. (2016) · Journal of Basic and Clinical Pharmacy · doi:10.4103/0976-0105.177703 · Cited by 6,174
Gomes, A. P., Price, N. L., Ling, A. J. Y., Moslehi, J. J., Montgomery, M. K., Rajman, L., White, J. P., Teodoro, J. S., Wrann, C. D., Hubbard, B. P., et al. (2013) · Cell · doi:10.1016/j.cell.2013.11.037 · Cited by 1,482
NAD+ and sirtuins in aging and disease
Imai, S.-I., & Guarente, L. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.04.002 · Cited by 1,481
NAD + in aging, metabolism, and neurodegeneration
Verdin, E. (2015) · Science · doi:10.1126/science.aac4854 · Cited by 1,319
NAD + repletion improves mitochondrial and stem cell function and enhances life span in mice
Zhang, H., Ryu, D., Wu, Y., Gariani, K., Wang, X., Luan, P., D’Amico, D., Ropelle, E. R., Lutolf, M. P., Aebersold, R., et al. (2016) · Science · doi:10.1126/science.aaf2693 · Cited by 1,255
Cantó, C., Houtkooper, R. H., Pirinen, E., Youn, D. Y., Oosterveer, M. H., Cen, Y., Fernandez-Marcos, P. J., Yamamoto, H., Andreux, P. A., Cettour-Rose, P., et al. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.022 · Cited by 1,238
New insights into the molecular and cellular functions of poly(ADP-ribose) and PARPs
Gibson, B. A., & Kraus, W. L. (2012) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3376 · Cited by 1,226
Mouchiroud, L., Houtkooper, R. H., Moullan, N., Katsyuba, E., Ryu, D., Cantó, C., Mottis, A., Jo, Y.-S., Viswanathan, M., Schoonjans, K., et al. (2013) · Cell · doi:10.1016/j.cell.2013.06.016 · Cited by 1,210
Revollo, J. R., Grimm, A. A., & Imai, S.-I. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m408388200 · Cited by 1,010
Bitterman, K. J., Anderson, R. M., Cohen, H. Y., Latorre-Esteves, M., & Sinclair, D. A. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m205670200 · Cited by 1,002
Slowing ageing by design: the rise of NAD+ and sirtuin-activating compounds
Bonkowski, M. S., & Sinclair, D. A. (2016) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm.2016.93 · Cited by 834
Nicotinamide riboside is uniquely and orally bioavailable in mice and humans
Trammell, S. A. J., Schmidt, M. S., Weidemann, B. J., Redpath, P., Jaksch, F., Dellinger, R. W., Li, Z., Abel, E. D., Migaud, M. E., & Brenner, C. (2016) · Nature Communications · doi:10.1038/ncomms12948 · Cited by 697
Wallerian degeneration: an emerging axon death pathway linking injury and disease
Conforti, L., Gilley, J., & Coleman, M. P. (2014) · Nature reviews. Neuroscience · doi:10.1038/nrn3680 · Cited by 630
Vitamin B 3 modulates mitochondrial vulnerability and prevents glaucoma in aged mice
Williams, P. A., Harder, J. M., Foxworth, N. E., Cochran, K. E., Philip, V. M., Porciatti, V., Smithies, O., & John, S. W. M. (2017) · Science · doi:10.1126/science.aal0092 · Cited by 617
Self-citationWallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene
Mack, T. G. A., Reiner, M., Beirowski, B., Mi, W., Emanuelli, M., Wagner, D., Thomson, D., Gillingwater, T., Court, F., Conforti, L., et al. (2001) · Nature Neuroscience · doi:10.1038/nn770 · Cited by 611
Axons of retinal ganglion cells are insulted in the optic nerve early in DBA/2J glaucoma
Howell, G. R., Libby, R. T., Jakobs, T., Smith, R. S., Phalan, F. C., Barter, J. W., Barbay, J. M., Marchant, J. K., Nagaraju, M., Porciatti, V., et al. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200706181 · Cited by 601
Self-citationEssential iris atrophy, pigment dispersion, and glaucoma in DBA/2J mice.
John, S. W. M., Smith, R. S., Savinova, O. V., Hawes, N. L., Chang, B., Turnbull, D., Davisson, M. T., Roderick, T. H., & Heckenlively, J. R. (1998) · PubMed · Cited by 549
Self-citationHowell, G. R., Macalinao, D. G., Sousa, G. L., Walden, M., Soto, I., Kneeland, S. C., Barbay, J. M., King, B. L., Marchant, J. K., Hibbs, M., et al. (2011) · Journal of Clinical Investigation · doi:10.1172/jci44646 · Cited by 473
Self-citationWallerian Degeneration, WldS, and Nmnat
Coleman, M. P., & Freeman, M. R. (2010) · Annual Review of Neuroscience · doi:10.1146/annurev-neuro-060909-153248 · Cited by 473
Avalos, J. L., Bever, K. M., & Wolberger, C. (2005) · Molecular Cell · doi:10.1016/j.molcel.2005.02.022 · Cited by 473
Axon degeneration: Molecular mechanisms of a self-destruction pathway
Wang, J. T., Medress, Z. A., & Barres, B. A. (2012) · The Journal of Cell Biology · doi:10.1083/jcb.201108111 · Cited by 464
Mutations in genes encoding melanosomal proteins cause pigmentary glaucoma in DBA/2J mice
Anderson, M. G., Smith, R. S., Hawes, N. L., Zabaleta, A., Chang, B., Wiggs, J. L., & John, S. W. M. (2001) · Nature Genetics · doi:10.1038/ng794 · Cited by 453
Self-citationTargeting Sirtuin 1 to Improve Metabolism: All You Need Is NAD+?
Cantó, C., & Auwerx, J. (2012) · Pharmacological Reviews · doi:10.1124/pr.110.003905 · Cited by 433
Safety of high-dose nicotinamide: a review
Knip, M., Douek, I. F., Moore, W. P. T., Gillmor, H. A., McLean, A. E. M., Bingley, P. J., & Gale, E. A. M. (2000) · Diabetologia · doi:10.1007/s001250051536 · Cited by 423
Inherited glaucoma in DBA/2J mice: Pertinent disease features for studying the neurodegeneration
Libby, R. T., Anderson, M. G., Pang, I., ROBINSON, Z. H., SAVINOVA, O. V., Cosma, I. M., Snow, A., Wilson, L. A., Smith, R. S., Clark, A. F., et al. (2005) · Visual Neuroscience · doi:10.1017/s0952523805225130 · Cited by 410
Self-citationGreen, K. N., Steffan, J. S., Martinez-Coria, H., Sun, X., Schreiber, S. S., Thompson, L. M., & LaFerla, F. M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.3203-08.2008 · Cited by 404
Biosynthesis of Diphosphopyridine Nucleotide
Preiss, J., & Handler, P. (1958) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)64789-1 · Cited by 403
Oxidative stress and mitochondrial dysfunction in glaucoma
Chrysostomou, V., Rezania, F., Trounce, I. A., & Crowston, J. G. (2013) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2012.09.008 · Cited by 403
NRK1 controls nicotinamide mononucleotide and nicotinamide riboside metabolism in mammalian cells
Ratajczak, J., Joffraud, M., Trammell, S. A. J., Ras, R., Canela, N., Boutant, M., Kulkarni, S. S., Rodrigues, M., Redpath, P., Migaud, M. E., et al. (2016) · Nature Communications · doi:10.1038/ncomms13103 · Cited by 378
Individual variability in human blood metabolites identifies age-related differences
Chaleckis, R., Murakami, I., Takada, J., Kondoh, H., & Yanagida, M. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1603023113 · Cited by 373
Nickells, R. W., Howell, G. R., Soto, I., & John, S. W. M. (2012) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.051508.135728 · Cited by 344
Self-citationMitochondrial Abnormalities in Patients with Primary Open-Angle Glaucoma
Abu‐Amero, K. K., Morales, J., & Bosley, T. M. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-1639 · Cited by 342
Bailey, J. N. C., Loomis, S. J., Kang, J. H., Allingham, R. R., Gharahkhani, P., Khor, C. C., Burdon, K. P., Aschard, H., Chasman, D. I., Igo, R. P., et al. (2016) · Nature Genetics · doi:10.1038/ng.3482 · Cited by 275
Stein, L. R., & Imai, S. (2014) · The EMBO Journal · doi:10.1002/embj.201386917 · Cited by 265
Optic nerve degeneration and mitochondrial dysfunction: genetic and acquired optic neuropathies
Carelli, V. (2002) · Neurochemistry International · doi:10.1016/s0197-0186(01)00129-2 · Cited by 264
Mitochondrial Dysfunction and Glaucoma
Kong, G. Y. X., Bergen, N. J. V., Trounce, I. A., & Crowston, J. G. (2009) · Journal of Glaucoma · doi:10.1097/ijg.0b013e318181284f · Cited by 261
Whitmore, A. V., Libby, R. T., & John, S. W. M. (2005) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2005.04.004 · Cited by 257
Self-citationA rise in NAD precursor nicotinamide mononucleotide (NMN) after injury promotes axon degeneration
Di Stefano, M., Nascimento-Ferreira, I., Orsomando, G., Mori, V, Gilley, J., Brown, R., Janeckova, L., Vargas, M. E., Worrell, L. A., Loreto, A., et al. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.164 · Cited by 246
Retinal ganglion cell neurodegeneration in mitochondrial inherited disorders
Carelli, V., Morgia, C. L., Valentino, M. L., Barboni, P., Ross‐Cisneros, F. N., & Sadun, A. A. (2009) · Biochimica et Biophysica Acta (BBA) - Bioenergetics · doi:10.1016/j.bbabio.2009.02.024 · Cited by 238
Magni, G., Amici, A., Emanuelli, M., Raffaelli, N., & Ruggieri, S. (1999) · Advances in enzymology and related areas of molecular biology/Advances in enzymology and related subjects · doi:10.1002/9780470123195.ch5 · Cited by 235
Endothelial dysfunction in glaucoma
Resch, H., Garhöfer, G., Fuchsjäger‐Mayrl, G., Hommer, A., & Schmetterer, L. F. (2008) · Acta Ophthalmologica · doi:10.1111/j.1755-3768.2007.01167.x · Cited by 206
Complement Component 1Q (C1Q) Upregulation in Retina of Murine, Primate, and Human Glaucomatous Eyes
Stasi, K., Nagel, D., Yang, X., Wang, R., Ren, L., Podos, S. M., Mittag, T. W., & Danias, J. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-0830 · Cited by 201
Chini, E. N. (2009) · Current Pharmaceutical Design · doi:10.2174/138161209787185788 · Cited by 198
NAMPT-Mediated NAD+ Biosynthesis Is Essential for Vision In Mice
Lin, J. B., Kubota, S., Ban, N., Yoshida, M., Santeford, A. C., Sène, A., Nakamura, R. E. I., Zapata, N., Kubota, M., Tsubota, K., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.08.073 · Cited by 189
Williams, P. A., Tribble, J. R., Pepper, K. W., Cross, S. D., Morgan, B. P., Morgan, J. E., John, S. W. M., & Howell, G. R. (2016) · Molecular Neurodegeneration · doi:10.1186/s13024-016-0091-6 · Cited by 183
Self-citationMouse models of retinal ganglion cell death and glaucoma
McKinnon, S. J., Schlamp, C. L., & Nickells, R. W. (2008) · Experimental Eye Research · doi:10.1016/j.exer.2008.12.002 · Cited by 182
Mitochondrial dysfunction in glaucoma and emerging bioenergetic therapies
Lee, S., Bergen, N. J. V., Kong, G. Y. X., Chrysostomou, V., Waugh, H. S., O’Neill, E. C., Crowston, J. G., & Trounce, I. A. (2010) · Experimental Eye Research · doi:10.1016/j.exer.2010.07.015 · Cited by 170
Christiaen, E., Goossens, M., Descamps, B., Boon, P., Raedt, R., & Vanhove, C. (2017) · Frontiers in Neuroscience · doi:10.3389/conf.fnins.2017.94.00011 · Cited by 153
Oral Microbiome Link to Neurodegeneration in Glaucoma
Astafurov, K. V., Elhawy, E., Ren, L., Dong, C. Q., Igboin, C. O., Hyman, L., Griffen, A. L., Mittag, T. W., & Danias, J. (2014) · PLoS ONE · doi:10.1371/journal.pone.0104416 · Cited by 146
Neuroprotection in glaucoma: recent and future directions
Danesh-Meyer, H. V. (2011) · Current Opinion in Ophthalmology · doi:10.1097/icu.0b013e32834372ec · Cited by 133
Mokudai, T., Ayoub, I. A., Sakakibara, Y., Lee, E.-J., Ogilvy, C. S., & Maynard, K. I. (2000) · Stroke · doi:10.1161/01.str.31.7.1679 · Cited by 131
Inman, D. M., Sappington, R. M., Horner, P. J., & Calkins, D. J. (2006) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.05-0925 · Cited by 126
Bergen, N. J. V., Crowston, J. G., Craig, J. E., Burdon, K. P., Kearns, L. S., Sharma, S., Hewitt, A. W., Mackey, D. A., & Trounce, I. A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0140919 · Cited by 124
Hepatic Toxicity from Large Doses of Vitamin B3(Nicotinamide)
Winter, S. L., & Boyer, J. L. (1973) · New England Journal of Medicine · doi:10.1056/nejm197311292892208 · Cited by 121
Harder, J. M., Braine, C., Williams, P. A., Zhu, X., MacNicoll, K. H., Sousa, G. L., Buchanan, R. A., Smith, R. S., Libby, R. T., Howell, G. R., et al. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1608769114 · Cited by 114
Self-citationVascular and autonomic dysregulation in primary open-angle glaucoma
Pasquale, L. R. (2015) · Current Opinion in Ophthalmology · doi:10.1097/icu.0000000000000245 · Cited by 114
Retinal Ganglion Cell Dendritic Atrophy in DBA/2J Glaucoma
Williams, P. A., Howell, G. R., Barbay, J. M., Braine, C., Sousa, G. L., John, S. W. M., & Morgan, J. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072282 · Cited by 110
Self-citationAxonal protection by Nmnat3 overexpression with involvement of autophagy in optic nerve degeneration
Kitaoka, Y., Munemasa, Y., Kojima, K., Hirano, A., Ueno, S., & Takagi, H. (2013) · Cell Death & Disease · doi:10.1038/cddis.2013.391 · Cited by 108
Nicotinamide and WLDS Act Together to Prevent Neurodegeneration in Glaucoma
Williams, P. A., Harder, J. M., Foxworth, N. E., Cardozo, B. H., Cochran, K. E., & John, S. W. M. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00232 · Cited by 107
Self-citationHowell, G. R., MacNicoll, K. H., Braine, C., Soto, I., Macalinao, D. G., Sousa, G. L., & John, S. W. M. (2014) · Neurobiology of Disease · doi:10.1016/j.nbd.2014.07.016 · Cited by 106
Self-citationIOP-Dependent Retinal Ganglion Cell Dysfunction in Glaucomatous DBA/2J Mice
Nagaraju, M., Saleh, M., & Porciatti, V. (2007) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0582 · Cited by 103
Effects of anti-glaucoma medications on ganglion cell survival: the DBA/2J mouse model.
Schuettauf, F., Quinto, K., Naskar, R., & Zurakowski, D. (2002) · PubMed · doi:10.1016/s0042-6989(02)00188-8 · Cited by 102
Effect of elevated intraocular pressure on endothelin-1 in a rat model of glaucoma
Prasanna, G., Hulet, C., Desai, D. H., Krishnamoorthy, R. R., Narayan, S., Brun, A.-M., Suburo, Á. M., & Yorio, T. (2004) · Pharmacological Research · doi:10.1016/j.phrs.2004.04.006 · Cited by 98
Mitochondrial dysfunction in glaucoma: Understanding genetic influences
Lascaratos, G., Garway‐Heath, D. F., Willoughby, C. E., Chau, K., & Schapira, A. H. V. (2011) · Mitochondrion · doi:10.1016/j.mito.2011.11.004 · Cited by 97
Kaushik, S., Pandav, S. S., & Ram, J. (2003) · Journal of Postgraduate Medicine · doi:10.4103/0022-3859.917 · Cited by 94
Sadun, A. A. (2002) · Seminars in Ophthalmology · doi:10.1076/soph.17.1.29.10290 · Cited by 92
Metabolic Vulnerability in the Neurodegenerative Disease Glaucoma
Inman, D. M., & Harun-Or-Rashid, M. (2017) · Frontiers in Neuroscience · doi:10.3389/fnins.2017.00146 · Cited by 88
Guan, X., Lin, P. C., Knoll, E., & Chakrabarti, R. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107729 · Cited by 87
Use of calcium channel blockers for glaucoma
Araie, M., & Mayama, C. (2010) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2010.09.002 · Cited by 87
Nicotinamide inhibits cyclic ADP-ribose-mediated calcium signalling in sea urchin eggs
Sethi, J. K., Empson, R. M., & Galione, A. (1996) · Biochemical Journal · doi:10.1042/bj3190613 · Cited by 84
Using genetic mouse models to gain insight into glaucoma: Past results and future possibilities
Fernandes, K. A., Harder, J. M., Williams, P. A., Rausch, R. L., Kiernan, A. E., Nair, K. S., Anderson, M. G., John, S. W. M., Howell, G. R., & Libby, R. T. (2015) · Experimental Eye Research · doi:10.1016/j.exer.2015.06.019 · Cited by 81
Self-citationApoptotic retinal ganglion cell death in the DBA/2 mouse model of glaucoma
Reichstein, D. A., Ren, L., Filippopoulos, T., Mittag, T. W., & Danias, J. (2006) · Experimental Eye Research · doi:10.1016/j.exer.2006.08.009 · Cited by 81
Nicotinamide benefits both mothers and pups in two contrasting mouse models of preeclampsia
Li, F., Fushima, T., Oyanagi, G., Townley-Tilson, H. W. D., Sato, E., Nakada, H., Oe, Y., Hagaman, J. R., Wilder, J., Li, M., et al. (2016) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1614947113 · Cited by 78
Ju, W., Keun-young Kim, A., Lindsey, J. D., Angert, M., Patel, A., Scott, R. T., Liu, Q., Crowston, J. G., Ellisman, M. H., Perkins, G. A., et al. (2009) · PubMed Central · Cited by 74
Khawaja, A. P., Bailey, J. N. C., Kang, J. H., Allingham, R. R., Hauser, M. A., Brilliant, M. H., Budenz, D. L., Christen, W. G., Fingert, J. H., Gaasterland, D., et al. (2016) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.16-20017 · Cited by 67
Zhu, Y., Zhang, L., Sasaki, Y., Milbrandt, J., & Gidday, J. M. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-10861 · Cited by 66
OPA1 increases the risk of normal but not high tension glaucoma
Yu‐Wai‐Man, P., Stewart, J. D., Hudson, G., Andrews, R. M., Griffiths, P. G., Birch, M., & Chinnery, P. F. (2009) · Journal of Medical Genetics · doi:10.1136/jmg.2009.067512 · Cited by 65
Endothelin antagonism as an active principle for glaucoma therapy
Rosenthal, R., & Fromm, M. E. (2010) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01103.x · Cited by 64
Krishnamoorthy, R. R., Rao, V. R., Dauphin, R., Prasanna, G., Johnson, C. A., & Yorio, T. (2008) · Canadian Journal of Physiology and Pharmacology · doi:10.1139/y08-040 · Cited by 63
Collins, D. W., Gudiseva, H. V., Trachtman, B. T., Bowman, A. S., Sagaser, A., Sankar, P. S., Miller-Ellis, E. G., Lehman, A. Y., Addis, V. M., & O’Brien, J. M. (2016) · PubMed Central · Cited by 61
Pelzel, H. R., Schlamp, C. L., Waclawski, M., Shaw, M. K., & Nickells, R. W. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.11-8872 · Cited by 60
Sundaresan, P., Simpson, D. A. C., Sambare, C., Duffy, S., Lechner, J., Dastane, A., Dervan, E. W. J., Vallabh, N. A., Chelerkar, V., Deshpande, M., et al. (2014) · Genetics in Medicine · doi:10.1038/gim.2014.121 · Cited by 57
Inhibition of cADP-Ribose Formation Produces Vasodilation in Bovine Coronary Arteries
Geiger, J., Zou, A.-P., Campbell, W. B., & Li, P. (2000) · Hypertension · doi:10.1161/01.hyp.35.1.397 · Cited by 57
Dependency of Intraocular Pressure Elevation and Glaucomatous Changes in DBA/2J and DBA/2J-Rj Mice
Scholz, M., Buder, T., Seeber, S., Adamek, E., Becker, C.-M., & Lu¨tjen-Drecoll, E. (2008) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.07-0745 · Cited by 51
Resistance to the most common optic neuropathy is associated with systemic mitochondrial efficiency
Lascaratos, G., Chau, K., Zhu, H., Gkotsi, D., King, R. H. M., Gout, I. T., Kamal, D., Luthert, P. J., Schapira, A. H. V., & Garway‐Heath, D. F. (2015) · Neurobiology of Disease · doi:10.1016/j.nbd.2015.05.012 · Cited by 50
Ganglion cell death in glaucoma: from mice to men
Nickells, R. W. (2007) · Veterinary Ophthalmology · doi:10.1111/j.1463-5224.2007.00564.x · Cited by 49
Mitochondrial Genome Analysis of Primary Open Angle Glaucoma Patients
Banerjee, D., Banerjee, A., Mookherjee, S., Vishal, M., Mukhopadhyay, A., Sen, A., Basu, A., & Ray, K. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070760 · Cited by 48
Plasma Citrate Levels as a Potential Biomarker for Glaucoma
Fraenkl, S. A., Muser, J. M., Groell, R., Reinhard, G., Orgül, S., Flammer, J., & Goldblum, D. (2011) · Journal of Ocular Pharmacology and Therapeutics · doi:10.1089/jop.2011.0062 · Cited by 47
Jeoung, J. W., Seong, M.-W., Park, S. S., Kim, D. M., Kim, S. H., & Park, K. H. (2014) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.13-12968 · Cited by 41
[Use of calcium channel blockers in glaucoma].
Melena, J., & Nn, O. (2000) · PubMed · Cited by 41
Thai, T. L., & Arendshorst, W. J. (2008) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00512.2007 · Cited by 38
Wong, A. A., & Brown, R. E. (2012) · Investigative Ophthalmology & Visual Science · doi:10.1167/iovs.12-10020 · Cited by 38
Role of HDACs in optic nerve damage-induced nuclear atrophy of retinal ganglion cells
Schmitt, H. M., Schlamp, C. L., & Nickells, R. W. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.12.012 · Cited by 37
Ocular Effects of Niacin: A Review of the Literature.
Domanico, D., Verboschi, F., Altimari, S., Zompatori, L., & Vingolo, E. M. (2015) · Medical Hypothesis Discovery & Innovation in Ophthalmology · Cited by 35
Leber's hereditary optic neuropathy mitochondrial DNA mutations in normal-tension glaucoma
Opial, D., Boehnke, M., Tadesse, S., Lietz-Partzsch, A., Flammer, J., Munier, F., Mermoud, A., Hirano, M., Flückiger, F., & Mojon, D. S. (2001) · Graefe's Archive for Clinical and Experimental Ophthalmology · doi:10.1007/s004170100309 · Cited by 32
Down-regulation of OPA1 in patients with primary open angle glaucoma.
Bosley, T. M., Hellani, A. M., Spaeth, G. L., Myers, J. S., Katz, L. J., Moster, M. R., Milcarek, B. I., & Abu‐Amero, K. K. (2011) · PubMed Central · Cited by 30
Mitochondrial Sequence Variation in African-American Primary Open-Angle Glaucoma Patients
Collins, D. W., Gudiseva, H. V., Trachtman, B. T., Jerrehian, M., Gorry, T., Merritt III, W. T., Rhodes, A. L., Sankar, P. S., Regina, M., Miller-Ellis, E., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076627 · Cited by 27
Mitochondrial DNA nucleotide changes in primary congenital glaucoma patients.
Kumar, M., Tanwar, M., Faiq, M. A., Pani, J., Shamsi, M. B., Dada, T., & Dada, R. (2013) · Europe PMC (PubMed Central) · Cited by 25
Nicking Glaucoma with Nicotinamide?
Liebmann, J. M., & Cioffi, G. A. (2017) · New England Journal of Medicine · doi:10.1056/nejmcibr1702486 · Cited by 22
Effect of Niacin on Retinal Vascular Diameter in Patients with Age-Related Macular Degeneration
Barakat, M., Metelitsina, T. I., DuPont, J. C., & Grunwald, J. E. (2006) · Current Eye Research · doi:10.1080/02713680600760501 · Cited by 15
Abu‐Amero, K. K., González, A. M., Osman, E. A., Larruga, J. M., Cabrera, V. M., & Al‐Obeidan, S. A. (2011) · PubMed Central · Cited by 13
Oral Niacin Can Increase Intraocular Pressure
Tittler, E. H., Barros, D. S., Navarro, J. B. V. K., Freitas, D. G. J., Gheith, M. E., Siam, G. A., & Spaeth, G. L. (2008) · Ophthalmic surgery, lasers & imaging retina · doi:10.3928/15428877-20080701-17 · Cited by 12
Mitochondrial genetic background in Ghanaian patients with primary open-angle glaucoma.
Abu‐Amero, K. K., Hauser, M. A., Mohamed, G., Liu, Y., Gibson, J., Gonzalez, A. M., Akafo, S., & Allingham, R. R. (2012) · Europe PMC (PubMed Central) · Cited by 11
Effect of Antiglaucoma Medicine on Intraocular Pressure in DBA/2J Mice
Sawada, K., Hiraoka, M., & Ohguro, H. (2016) · Ophthalmic Research · doi:10.1159/000444057 · Cited by 5
Cited by
Sorted by citations
Tribble, J. R., Otmani, A., Sun, S., Ellis, S. A., Cimaglia, G., Vohra, R., Jöe, M., Lardner, E., Venkataraman, A. P., Domínguez‐Vicent, A., et al. (2021) · Redox Biology · doi:10.1016/j.redox.2021.101988 · Cited by 236
Self-citationHui, F., Tang, J., Williams, P. A., McGuinness, M. B., Hadoux, X., Casson, R. J., Coote, M., Trounce, I. A., Martin, K. R., van Wijngaarden, P., et al. (2020) · Clinical & Experimental Ophthalmology · doi:10.1111/ceo.13818 · Cited by 226
Self-citationNicotinamide and Pyruvate for Neuroenhancement in Open-Angle Glaucoma
Moraes, C. G. D., John, S. W. M., Williams, P. A., Blumberg, D. M., Cioffi, G. A., & Liebmann, J. M. (2021) · JAMA Ophthalmology · doi:10.1001/jamaophthalmol.2021.4576 · Cited by 166
Self-citationPossible Adverse Effects of High-Dose Nicotinamide: Mechanisms and Safety Assessment
Hwang, E., & Song, S. (2020) · Biomolecules · doi:10.3390/biom10050687 · Cited by 144
Retinal energy metabolism in health and glaucoma
Casson, R. J., Chidlow, G., Crowston, J. G., Williams, P. A., & Wood, J. P. M. (2020) · Progress in Retinal and Eye Research · doi:10.1016/j.preteyeres.2020.100881 · Cited by 132
Self-citation
Metadata
- Authors
- Williams, P. A., Harder, J. M., & John, S. W. M.
- Affiliations
- Howard Hughes Medical Institute (US)
- Tufts University (US)
- Corresponding author
- Williams, Pete A.
- Harder, Jeffrey M.
- John, Simon W.M.
- Venue
- Journal of Glaucoma
- Published
- 2017-12
- Volume
- 26
- Issue
- 12
- Pages
- 1161-1168
- ISSN
- 1057-0829 (ISSN-L)
- PMC
- PMC5854489
- OpenAlex
- W2753388315
- Cited by
- 102
- References
- 108
- Citations by year
- 2026: 10 · 2025: 14 · 2024: 8 · 2023: 17 · 2022: 12 · 2021: 19 · 2020: 13 · 2019: 5 · 2018: 4
- FWCI
- 1.10
- Type
- journal article
- Language
- en
- Open access
- green
- europepmc.org
- Locations
- Journal of Glaucoma (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- The Mouseion at the JAXlibrary (Jackson Laboratory) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- National Eye Institute (R01EY011721)
- Eunice Kennedy Shriver National Institute of Child Health and Human Development (T32HD007065)
- Topics
- Health Sciences › Medicine › Ophthalmology › Glaucoma and retinal disorders
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Life Sciences › Neuroscience › Neurology › Neuroprotection in Cerebral Ischemia
- Keywords
- glaucoma, nicotinamide, NAD+, mitochondrial dysfunction, retinal ganglion cells, intraocular pressure, neuroprotection, NAD+ precursors, glaucoma prevention
- MeSH terms
- Animals, Glaucoma, Humans, Intraocular Pressure, Niacinamide, Optic Nerve Diseases, Vitamin B Complex
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
